Abstract: Radiotracers offer unique options for brain imaging of functional and molecular processes related to hearing. Such imaging can be applied in a broad spectrum of situations from preclinical research to clinical patient care. Functional imaging to assess activation in brain regions and networks involved in auditory processing uses markers of blood flow or energy-metabolism in well-defined conditions with and without auditory stimulation. Molecular markers can be used in hearing research for example to study changes in inhibitory neurotransmission systems related to hearing loss. For imaging either positron emission tomography (PET) or single-photon emission computed tomography (SPECT) are employed. Data analysis can encompasses voxel-wise statistical analysis of activation and calculation of quantitative parameters like receptor binding-potentials based on bio-kinetic modeling. Functional imaging has been frequently used in the context of auditory implantation. Before implantation it aims to assess intactness of the central auditory pathway and prognosis. After implantation it is used to improve understanding of the outcome with respect to auditory function and finally speech understanding, e.g. by measuring correlates of central auditory processing and neuroplasticity.
Procedures

Radiotracer
Brain regions and networks involved in processing of simple or complex auditory stimuli -e.g. like tones or speech -can be studied using radioactively labelled markers of neuronal activity. Specifically markers of blood flow like 15 Furthermore, molecular structures involved in auditory processing like neuro-receptors can be measured using radiotracers. This is of particular interest for inhibitory neurotransmission systems. Changes of these in auditory regions e.g. due to hearing loss or reflecting neuroplasticity are suggested by experimental data. One example is the inhibitory GABAergic system. The radiotracer 18 F-flumazenil allowing to measure GABA A receptor binding has already been employed in hearing research.
Imaging devices
The radiotracer distribution e.g. in the brain can be measured by emission tomography. Depending on the type of isotope used for labelling either single-photon emission computed tomography (SPECT, for gamma emitters) or positron emission tomography (PET, for positron emitters) is employed. In comparison to functional magnetic resonance imaging (fMRI) both devices have the advantages to be relatively quite imaging modalities and the option of measuring patients with implants without safety concerns. PET scanners have been fundamentally improved technically in the last two decades [1] . A spatial resolution down to 2 mm (full width at half maximum), and sensitivity up to 9.5 cps/kBq has been achieved. This is considerably superior to SPECT devices, with about 4-5 times lower spatial resolution and up to 100 fold lower sensitivity.
Data analysis
The simplest form to assess functional activations in the auditory system is based on always one image obtained ______ *Corresponding author: Georg Berding: Department of Nuclear Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany, e-mail: berding.georg@mh-hannover.de Thomas Lenarz: Institution, Department of Otolaryngology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany, e-mail: lenarz.thomas@mh-hannover.de during silence and one during stimulation of the auditory system (see Figure 1 ). Images of subtraction (stimulationsilence) as well as percent activation of normalized counts registered for auditory regions can be calculated. A more sophisticated approach is based on repeated measures of conditions -e.g. always 6 times alternating silence and stimulation. This enables analysis using statistical parametric mapping. For this analysis 3D data sets are first transferred into an anatomical stereotaxic standard space and thereafter all scaled in the same way e.g. by normalization to the respective average counts in the brain. Finally a statistical test (e.g. t-test) is performed for each resolution element (voxel) of the 3D data sets to obtain statistical parameter values reflecting the magnitude of the difference between studies obtained during stimulation vs. those obtained during silence (i.e. activation). Finally, relevant activations are recognized, by applying an adequate threshold of significance (e.g. p<0.001, uncorrected for multiple comparisons).
For quantification of neuro-receptor studies, bio-kinetic modeling is used. Receptor binding potentials are calculated based on radiotracer input functions (measured from blood samples or reference tissue measured in the scanner) and tissue response curves (measured in the scanner for tissue with specific tracer binding) [2] .
Results
Assessment before implantation
Resting state 18 F-FDG PET studies have been performed in deaf children before cochlear implantation to assess the prognosis with respect to the achieved speech comprehension A significant negative correlation has been demonstrated between tracer uptake in auditory regions and the performance in a sentence comprehension test achieved 3 years after implantation. This has been explained by a cross modal occupation of auditory regions by visual functions.
The data indicate a prognostic relevance of resting metabolism in auditory regions before implantation [3] . Functionality of the central hearing pathway can be assessed using a trans-tympanic needle electrode placed at the promontory (adjacent to the cochlear). The electrode induces direct stimulation of the spiral ganglion / auditory nerve. Promontory simulation has been shown to induce about 20% of increase in blood flow in the auditory cortex (as measured by 
Plasticity after cochlear Implantation
After successful cochlear implantation resting activity in auditory regions in the temporal cortex (temporal voice area) decreases because compensatory visual activity is gradually replaced by speech related activity [5] . Moreover, with time after implantation activation in the inferior frontal cortex (Broca area) increases reflecting the auditory rehabilitation process in this region relevant for speech perception and production [6] .
Furthermore, improved activation in auditory networks has been demonstrated together with bilateral in contrast to unilateral cochlear implantation. Bilateral implantation recruited more equally auditory cortices in both hemispheres [7] . Finally, binaural vs. monaural discrimination of voice vs. non-voice stimuli revealed, that binaural implant stimulation is associated with activation in right fronto-parietal networks contributing to improved task performance [8] .
Results after brainstem implantation
This subchapter shows exemplarily the potential of 15 O-water PET to reflect speech processing in patients with new types of auditory implants. Due to the post cochlear cause of deafness (loss of the auditory nerve due to vestibular schwannoma) hearing could not be restored by a cochlear implant in these patients (n=7). Instead auditory midbrain implants (ABIs) to the cochlear nucleus were applied. Table  1 outlines the test procedure for the speech performance achieved in these patients applied after a mean period of 8 months. Table 2 ). 
Relevance of stimuli
Timing and type of stimulus used in auditory activation studies with radiotracers is of major importance. This can be exemplified e.g. in studies of loudness adaptation, a phenomenon observed in auditory implant users, which is characterized by a loss of loudness perception with a continuous multi-tone stimulus after a particular time period. The phenomenon is associated with lacking activation in auditory regions and additional activation in networks of auditory processing including the ventral frontal cortex [9] . These correlates of deficient processing cannot be observed if e.g. speech instead of a muti-tone complex is used even with identical timing.
Neurotransmission
Experimental ex vivo data indicates a relevance of inhibitory neurotransmission systems like the GABAergic system in various alterations of the hearing system like: age related hearing loss, tinnitus and neuro-plastic changes in the central auditory system. Preliminary preclinical studies indicate that at least in profound hearing loss a reduction in GABA A receptor binding can be detected in vivo in longitudinal studies using 18 F-flumazenil PET [10] .
Conclusion
Radiotracer imaging provides a broad spectrum of methods useful to detect with respect to hearing from basic functionalities -like the intactness of the central auditory pathway up to complex issues -like neuro-plastic changes occurring after auditory implantation. Furthermore the methodology is a research tool for further studies aiming to reveal the neurotransmission of hearing in vivo.
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